Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Pest Management Science, Wiley, Vol. 75, No. 4 ( 2019-04), p. 1115-1122
    Abstract: Given the lack of vaccines for most vector‐borne diseases, vector control is often the primary option for disease control. Aedes albopictus are difficult to control because the immatures primarily develop in containers ubiquitous in residential properties. Conventional adulticide campaigns often result in brief, rebounding population declines, so incorporating new techniques into an integrated pest management program is imperative. We performed combined area‐wide applications of the larvicides Bacillus thuringiensis var . israelensis and pyriproxyfen with the adulticide sumithrin and prallethrin to achieve extended suppression of Ae . albopictus populations in Trenton, NJ, USA. We deployed bioassay cups to assess the spatial penetration and efficacy of the applications. RESULTS Inhibition of adult emergence was significantly higher in the treatment bioassay cups than in laboratory controls (z = 4.65, P 〈 0.0001) and field control bioassay cups (z = 8.93, P 〈 0.0001). We observed a lower trend in adult numbers following season‐long combined application of pyriproxyfen and adulticide, with numbers of adult Ae. albopictus at the treatment site up to five times lower than at the control site. CONCLUSION Pyriproxyfen is a powerful mosquito larvicide and pupacide with low mammalian toxicity that shows promise for area‐wide vehicle‐mounted (either ground or airborne) applications. © 2018 Society of Chemical Industry
    Type of Medium: Online Resource
    ISSN: 1526-498X , 1526-4998
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2019
    detail.hit.zdb_id: 2003455-6
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages